Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.20B.
ENTERPRISE VALUE (EV)
$1.20B
ORIC Pharmaceuticals, Inc.
Market Cap
$1.23B
Enterprise Value (EV)
$1.20B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| ORIC Pharmaceuticals, Inc. (ORIC) | $1.23B | $1.20B |
| Omada Health (OMDA)vs › | $1.23B | $1.01B |
| Cronos Group Inc. (CRON)vs › | $1.23B | $759.89M |
| Innovage Holding Corp. (INNV)vs › | $1.22B | $1.21B |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.21B | $671.78M |
| Tyra Biosciences, Inc. (TYRA)vs › | $1.20B | $1.14B |
| Kardigan, Inc. (KARD)vs › | $1.20B | $829.17M |
| MannKind Corporation (MNKD)vs › | $1.18B | $1.46B |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.31B | $1.30B |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.32B | $1.08B |
Market Cap
$1.23B
Total Debt
$7.44M
Cash
$45.67M
Enterprise Value
$1.20B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
